The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2018040443
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Renin – Angiotensin System (RAS) and Hypertensive Disease"From the Link in Pathophysiology to the Outcomes of Inhibition"

Annals of the College of Medicine, Mosul
2009English

Effects of Transplantation on the Renin Angiotensin System (RAS)

Journal of Human Hypertension
Internal Medicine
1998English

Renin-Angiotensin System Inhibition-It's Been a Long but Fruitful Journey

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

The Relentless Crumbling of the Renin-Angiotensin System (RAS)-blockade Halo

Annals of Translational Medicine
Medicine
2016English

Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels Among Peritoneal Dialysis Patients

American Journal of Nephrology
Nephrology
2017English

Influenza Vaccination in the Elderly: 25 Years Follow-Up of a Randomized Controlled Trial. No Impact on Long-Term Mortality

PLoS ONE
Multidisciplinary
2019English

Inhibition of the Renin–angiotensin System and Target Organ Protection

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2009English

The Cholegas Trial: Long-Term Results of Prophylactic Cholecystectomy During Gastrectomy for Cancer—a Randomized-Controlled Trial

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

Controversies of Renin–angiotensin System Inhibition During the COVID-19 Pandemic

Nature Reviews Nephrology
Nephrology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy